Area of research
Cardiology and Cardiovascular Medicine · Economics and Econometrics
Research interest
Research interests include Heart Failure Treatment and Management, Health Systems, Economic Evaluations, Quality of Life, Atrial Fibrillation Management and Outcomes, and Cardiac pacing and defibrillation studies.
Cardiovascular Statistics in the United States, 2026
Needles in a Haystack: Finding Qualitative and Quantitative Collaborators in Academic Medical Centers
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
The role of machine learning in clinical research: transforming the future of evidence generation
Correction to: The role of machine learning in clinical research: transforming the future of evidence generation
The Emergence of Population Health in US Academic Medicine
Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation
Clinical Effectiveness of Sacubitril/valsartan among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction
Home-Time After Discharge Among Patients Hospitalized With Heart Failure
Hospital and clinical care costs associated with atrial fibrillation for Medicare beneficiaries in the Cardiovascular Health Study and the Framingham Heart Study
Intentional and unintentional medication non-adherence in African Americans: Insights from the Jackson Heart Study
Early Adoption of Sacubitril/Valsartan for Patients With Heart Failure With Reduced Ejection Fraction
Pericardial fat volume and incident atrial fibrillation in the Multi‐Ethnic Study of Atherosclerosis and Jackson Heart Study
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease
Long‐Term Outcomes Among Elderly Survivors of Out‐of‐Hospital Cardiac Arrest
Clinical Effectiveness of Hydralazine–Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry
Contraindications to Anticoagulation Therapy and Eligibility for Novel Anticoagulants in Older Patients with Atrial Fibrillation
Launching PCORnet, a national patient-centered clinical research network
Long-term Outcomes Following Development of New-Onset Atrial Fibrillation During Sepsis
In‐Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization
Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: Incidence and risk factors
Validated, Electronic Health Record Deployable Prediction Models for Assessing Patient Risk of 30-Day Rehospitalization and Mortality in Older Heart Failure Patients
QRS Duration, Bundle-Branch Block Morphology, and Outcomes Among Older Patients With Heart Failure Receiving Cardiac Resynchronization Therapy
Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure
Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction
Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007
The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction
Outcomes of Medicare Beneficiaries Undergoing Catheter Ablation for Atrial Fibrillation
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction